Effects of the MCP-1 synthesis inhibitor bindarit on tumorigenesis and inflammatory markers in the C3(1)/SV40Tag mouse model of breast cancer

Cytokine

Volumn 66, Issue 1, 2014, Pages 60-68

  Steiner, J L ^a,b   Davis, J M ^b   McClellan, J L ^a,b   Guglielmotti, A ^c   Murphy, E A ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c Università Politecnica delle Marche ACRAF Gruppo Angelini   (Italy)

Author keywords

Bindarit; C3(1) SV40Tag transgenic mice; Mammary cancer; MCP 1

Indexed keywords

BINDARIT; C3(1)/SV40TAG TRANSGENIC MICE; MAMMARY CANCER; MCP-1;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; BIOLOGICAL MARKERS; BODY WEIGHT; CARCINOGENESIS; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; FEEDING BEHAVIOR; FEMALE; GENE EXPRESSION REGULATION; INDAZOLES; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MACROPHAGES; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, TRANSGENIC; ORGAN SIZE; PROPIONATES; RNA, MESSENGER; SPLEEN; TUMOR BURDEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84893368555     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.12.011     Document Type: Article

References (42)

1. Siegel R., et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011, 61(4):212-236.
2. Condeelis J., Pollard J.W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006, 124(2):263-266.
3. Mantovani A. Cancer: inflaming metastasis. Nature 2009, 457(7225):36-37.
4. Pollard J.W. Macrophages define the invasive microenvironment in breast cancer. J Leukoc Biol 2008, 84(3):623-630.
5. Bingle L., Brown N.J., Lewis C.E. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002, 196(3):254-265.
6. Leek R.D., et al. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 1996, 56(20):4625-4629.
7. Ueno T., et al. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 2000, 6(8):3282-3289.
8. Balkwill F.R., Mantovani A. Cancer-related inflammation: Common themes and therapeutic opportunities. Semin Cancer Biol 2012, 22(1):33-40.
9. Valkovic T., et al. Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer. Pathol Res Pract 1998, 194(5):335-340.
10. Goede V., et al. Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer 1999, 82(5):765-770.
11. Chavey C., et al. Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Res 2007, 9(1):R15.
12. Soria G., Ben-Baruch A. The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett 2008, 267(2):271-285.
13. Luboshits G., et al. Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res 1999, 59(18):4681-4687.
14. Soria G., et al. Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions. Cytokine 2008, 44(1):191-200.
15. Fujimoto H., et al. Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression. Int J Cancer 2009, 125(6):1276-1284.
16. Mirolo M., et al. Impact of the anti-inflammatory agent bindarit on the chemokinome: selective inhibition of the monocyte chemotactic proteins. Eur Cytokine Netw 2008, 19(3):119-122.
17. Gazzaniga S., et al. Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft. J Invest Dermatol 2007, 127(8):2031-2041.
18. Zollo M., et al. Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models. Clin Exp Metastasis 2012, 29(6):585-601.
19. Green J.E., et al. The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma. Oncogene 2000, 19(8):1020-1027.
20. Maroulakou I.G., et al. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. Proc Natl Acad Sci USA 1994, 91(23):11236-11240.
21. Murphy E.A., et al. Benefits of exercise training on breast cancer progression and inflammation in C3(1)SV40Tag mice. Cytokine 2011, 55(2):274-279.
22. Cioli V., et al. A new protein antidenaturant agent, bindarit, reduces secondary phase of adjuvant arthritis in rats. J Rheumatol 1992, 19(11):1735-1742.
23. Guglielmotti A., et al. Chronic inflammatory response in the rat can be blocked by bindarit. Biochem Mol Biol Int 1993, 29(4):747-756.
24. Shibata M.A., et al. The C3(1)/SV40 T antigen transgenic mouse model of prostate and mammary cancer. Toxicol Pathol 1998, 26(1):177-182.
25. Calvo A., et al. Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin. Int J Cancer 2002, 101(3):224-234.
26. Steiner J.L., et al. Exercise training increases mitochondrial biogenesis in the brain. J Appl Physiol 2011, 111(4):1066-1071.
27. Steiner J.L., Murphy E.A. Importance of chemokine (CC-motif) ligand 2 in breast cancer. Int J Biol Markers 2012.
28. Saji H., et al. Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma. Cancer 2001, 92(5):1085-1091.
29. Soria G., et al. Inflammatory mediators in breast cancer: Coordinated expression of TNF alpha & IL-1 beta with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition. Bmc Cancer 2011, 11.
30. Valkovic T., et al. Macrophage level is not affected by monocyte chemotactic protein-1 in invasive ductal breast carcinoma. J Cancer Res Clin Oncol 2005, 131(7):453-458.
31. Dwyer R.M., et al. Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin Cancer Res 2007, 13(17):5020-5027.
32. Kulbe H., et al. The chemokine network in cancer - much more than directing cell movement. Int J Dev Biol 2004, 48(5-6):489-496.
33. Salcedo R., et al. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 2000, 96(1):34-40.
34. Zhou G.X., et al. Protective effects of MCP-1 inhibitor on a rat model of severe acute pancreatitis. Hepatobiliary Pancreat Dis Int 2010, 9(2):201-207.
35. Grassia G., et al. The anti-inflammatory agent bindarit inhibits neointima formation in both rats and hyperlipidaemic mice. Cardiovasc Res 2009, 84(3):485-493.
36. Mora E., et al. Bindarit: an anti-inflammatory small molecule that modulates the NFkappaB pathway. Cell Cycle 2012, 11(1):159-169.
37. Wigginton J.M., et al. Complete regression of established spontaneous mammary carcinoma and the therapeutic prevention of genetically programmed neoplastic transition by IL-12/pulse IL-2: induction of local T cell infiltration, Fas/Fas ligand gene expression, and mammary epithelial apoptosis. J Immunol 2001, 166(2):1156-1168.
38. Ono M. Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci 2008, 99(8):1501-1506.
39. Balkwill F., Charles K.A., Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005, 7(3):211-217.
40. Goldberg J.E., Schwertfeger K.L. Proinflammatory cytokines in breast cancer: mechanisms of action and potential targets for therapeutics. Curr Drug Targets 2010, 11(9):1133-1146.
41. Madhusudan S., et al. A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer. Clin Cancer Res 2004, 10(19):6528-6534.
42. Sironi M., et al. A small synthetic molecule capable of preferentially inhibiting the production of the CC chemokine monocyte chemotactic protein-1. Eur Cytokine Netw 1999, 10(3):437-442.